Elicio Therapeutics ELTX
NASDAQ ELTX
$3.04 -0.04 (-1.14%)
At close: Aug 21, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Revenue Growth (1y) (2021 - 2022)

Elicio Therapeutics (ELTX) Revenue Growth (1y) (2021 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 12.45%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 16.73%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 59.71%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.11%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 29.63%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 66.86%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -99.97%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 296.11%
9 Royalty Pharma 27.27 Bn 26.43 Bn - 16.50%
10 Elicio Therapeutics 58.41 Mn 34.91 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 20.93%
Mar 31, 2022 344.20%
Dec 31, 2021 5,551.63%
Sep 30, 2021 76.54%
Jun 30, 2021 -25.93%